A detailed history of Four Thought Financial, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Four Thought Financial, LLC holds 256 shares of CRL stock, worth $50,117. This represents 0.01% of its overall portfolio holdings.

Number of Shares
256
Previous 211 21.33%
Holding current value
$50,117
Previous $45,000 11.11%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 21, 2022

BUY
$182.44 - $250.54 $8,209 - $11,274
45 Added 21.33%
256 $50,000
Q2 2022

Aug 12, 2022

SELL
$204.13 - $302.4 $408 - $604
-2 Reduced 0.94%
211 $45,000
Q4 2021

Jan 14, 2022

SELL
$351.38 - $448.68 $15,109 - $19,293
-43 Reduced 16.8%
213 $80,000
Q1 2021

Nov 12, 2021

SELL
$249.67 - $299.48 $749 - $898
-3 Reduced 1.16%
256 $74,000
Q4 2020

Nov 12, 2021

BUY
$222.0 - $252.62 $57,498 - $65,428
259 New
259 $64,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.